FACTBOX-Johnson & Johnson’s recent product recalls

Sept 28 (BestGrowthStock) – Johnson & Johnson (JNJ.N: ) faces a
second congressional hearing on Thursday over its recall of
widely used over-the-counter medicines. [ID:nN28210874]

The diversified healthcare company’s McNeil consumer
product unit has announced several product recall in the past
20 months. Below are details of those withdrawals.

July 8, 2010:

Products: Twenty-one lots of Tylenol for children and
adults, several forms of Benadryl and Motrin sold in the United
States, Fiji, Guatemala, the Dominican Republic, Puerto Rico,
Trinidad and Tobago and Jamaica in expansion of Jan 15 recall.
The company has said this action affected 2.5 million bottles
of medicines.

Problem: musty or moldy odor detected in earlier recall.

June 15, 2010:

Products: Four lots of Benadryl and Extra Strength Tylenol
gels sold in the United States, Trinidad and Tobago, Bermuda
and Puerto Rico in expansion of Jan. 15 recall. The company has
said 500,000 bottles were affected.

Problem: musty or moldy odor detected in earlier recall.

April 30, 2010:

Products: Forty products including liquid infant and
children’s pain relievers, Tylenol, and Motrin and allergy
medications Zyrtec and Benadryl. About 135 million bottles were
affected, according to congressional investigators.

Problem: Manufacturing deficiencies that may have affected
the quality, purity or potency of the medicines.

January 15, 2010:

Products: Fifty-three million bottles of over-the-counter
products including Tylenol, Motrin and Rolaids, Benadryl and
St. Joseph’s Aspirin, involving lots in the Americas, the
United Arab Emirates and Fiji.

Problem: Unusual moldy, musty or mildew-like odor linked to
chemical in wood pallets used to store and ship products.

December 2009:

Product: Expands November recall of Tylenol Arthritis Pain
Caplets

Problem: Consumer reports of unusual moldy odor with the
100-count bottles.

November 2009:

Product: Five lots of Tylenol Arthritis Pain Caplets

Problem: Reports of an unusual musty or mildew-like odor
that was associated with nausea, stomach pain, vomiting and
diarrhea.

September 2009:

Products: Some lots of infants’ and children’s Tylenol

Problem: Possible bacterial contamination

July 2009:

Product: Motrin tablets sold mostly at convenience stores.
The recall is the subject of a congressional probe into what
some Democratic lawmakers say was a stealthy effort to buy back
the drug rather than recall it. J&J has said FDA knew of their
actions, while FDA has said as soon as it found out, it sought
a recall.

Problem: Problems with dissolving

November 2008:

Product: About 12,000 bottles of Mylicon over-the-counter
infant anti-gas drops in the dye-free variety. (Sold in a 50-50
joint venture with Merck & Co (MRK.N: ))

Problem: Bottles may have contained metal fragments.
(Compiled by Bill Berkrot and Phil Wahba in New York, and
Susan Heavey in Washington; Editing by Tim Dobbyn)

FACTBOX-Johnson & Johnson’s recent product recalls